greeksoup/ stock research

Indivior Pharmaceuticals, Inc. SEC filings

Indivior Pharmaceuticals (INDV) filed its 10-Q for the quarter ended 30 June 2026 on 3 August 2026. Its latest SEC filing, on 6 October 2026, was an 8-K: other events. 31 filings in the last twelve months, each 8-K by what it was about; the 10-K and proxy statement are on the documents page.

In the twelve months since 11 October 2025 Indivior Pharmaceuticals, Inc. filed 31 documents with the SEC of the kinds listed here: 22 current reports (8-K), about 13 regulation FD disclosure; 6 other events; 4 results of operations; 3 termination of a material agreement; 3 material agreement; 3 quarterly reports (10-Q), 1 merger registration (S-4), 1 annual report to shareholders (ARS), 1 additional proxy material (DEFA14A), 1 proxy statement (DEF 14A), 1 annual report (10-K). The latest, filed 6 October 2026: 8-K, other events. The 10-K, the 10-Qs and the proxy statement themselves, each with a link to open it, are on the documents page.

FiledFormWhat it was aboutPeriod or event dateFiling
6 October 20268-KOther events6 October 2026EDGAR
17 September 20268-KRegulation FD disclosure, Other events16 September 2026EDGAR
15 September 20268-KTermination of a material agreement9 September 2026EDGAR
28 August 2026S-4merger registrationEDGAR
3 August 202610-Qquarterly report30 June 2026EDGAR
3 August 20268-KRegulation FD disclosure3 August 2026EDGAR
3 August 20268-KResults of operations, Regulation FD disclosure3 August 2026EDGAR
3 August 20268-KMaterial agreement, Regulation FD disclosure1 August 2026EDGAR
15 May 20268-KOfficer or director change, Shareholder vote13 May 2026EDGAR
4 May 20268-KRegulation FD disclosure, Other events4 May 2026EDGAR
30 April 202610-Qquarterly report31 March 2026EDGAR
30 April 20268-KResults of operations, Regulation FD disclosure30 April 2026EDGAR
27 March 2026ARSannual report to shareholders31 December 2025EDGAR
27 March 2026DEFA14Aadditional proxy materialEDGAR
27 March 2026DEF 14Aproxy statement13 May 2026EDGAR
17 March 20268-KMaterial agreement, Termination of a material agreement, New financial obligation, Unregistered sale of equity17 March 2026EDGAR
13 March 20268-KOther events12 March 2026EDGAR
12 March 20268-KOther events12 March 2026EDGAR
26 February 202610-Kannual report31 December 2025EDGAR
26 February 20268-KResults of operations, Regulation FD disclosure26 February 2026EDGAR
26 January 2026S-8employee share plan registrationEDGAR
26 January 20268-KMaterial agreement, New financial obligation, Unregistered sale of equity, Change to security holders' rights, Change in control, Officer or director change, Charter or bylaw amendment, or fiscal year change, Code of ethics amendment, Regulation FD disclosure, Other events23 January 2026EDGAR
8 January 20268-KRegulation FD disclosure8 January 2026EDGAR
22 December 20258-KRegulation FD disclosure22 December 2025EDGAR
18 December 20258-KOfficer or director change12 December 2025EDGAR
15 December 20258-KCharter or bylaw amendment, or fiscal year change, Shareholder vote11 December 2025EDGAR
20 November 20258-KTermination of a material agreement, Regulation FD disclosure20 November 2025EDGAR
14 November 20258-KRegulation FD disclosure14 November 2025EDGAR
30 October 202510-Qquarterly report30 September 2025EDGAR
30 October 20258-K/AExit or disposal costs26 August 2025EDGAR
30 October 20258-KResults of operations, Regulation FD disclosure30 October 2025EDGAR
An 8-K is what a company files within four business days of a material event; the SEC numbers the events, and the words here are the SEC's own headings, shortened.
Read moreForm 4, Form 144, 13F and Schedule 13D and 13G have their own pages. Prospectus supplements and correspondence are not listed.

Source

The company's filing index on EDGAR, read from the SEC's submissions feed.

The same record on your computer

GreekSoup is also a free program for your own computer. It reads these same filings for the names you follow, refreshed as they land, with no account. One pasted line installs it.

Install